Bringing the fundamentals into focus…
Back to BridgeBio Oncology Therapeutics, Inc.
How BridgeBio Oncology Therapeutics, Inc. stacks up
BBOT · against 212 other Healthcare companies of similar size
Profitability
14/ 100
Near the bottom of its peers.
Ranked #161 of 213 · scores higher than 24% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 10–19, including BBOT · Click a bar to see the companies
Why profitability scores 14?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 93% of peers. Return on assets: -48.3% vs peer median 1.7%
- a lower return on invested capital: weaker than 89% of peers. Return on invested capital: -58.4% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = BBOT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BBOT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 175 reported | -58.4% | -3.3% | 22% | 33% | |
| Operating marginHigher is better · 193 reported | Not reported | 0.3% | — | — | 33% |
| Return on assetsHigher is better · 216 reported | -48.3% | -2.2% | 13% | 33% | |
| Return on equityHigher is better · 199 reported | -81.9% | -5.8% | 12% | Context only | |
| Gross marginHigher is better · 229 reported | 0.0% | 41.3% | 7% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around BBOT| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 301M USD | 95 | 67 | |
| 155 | 275M USD | 15 | 46 | |
| 155 | 107M USD | 15 | 31 | |
| 155 | 139M USD | 15 | 32 | |
| 161 | 11.6B TWD (≈$360M) | 14 | 45 | |
| 161 | 186M USD | 14 | 43 | |
| 161 | 170M USD | 14 | 35 | |
| 164 | 198M USD | 13 | 10 | |
| 164 | 5.1B MXN (≈$274M) | 13 | 48 | |
| 166 | 337M USD | 12 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score